No Data
No Data
Travere Therapeutics, Inc. (NASDAQ:TVTX) Held Back By Insufficient Growth Even After Shares Climb 31%
Travere Therapeutics, Inc. (NASDAQ:TVTX) shares have continued their recent momentum with a 31% gain in the last month alone. Unfortunately, the gains of the last month did little to right the
10 Health Care Stocks Whale Activity In Today's Session
This whale alert can help traders discover the next big trading opportunities.Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity
Nvidia, Micron Leading Chip Stocks Higher Tuesday
U.S. stocks were mixed, with the Dow Jones index falling around 100 points on Tuesday.Shares of NVIDIA Corporation (NASDAQ:NVDA) rose during Tuesday's session.Keybanc analyst John Vinh maintained
Travere Therapeutics to Present at the H.C. Wainwright 3rd Annual Kidney Virtual Conference
SAN DIEGO, July 08, 2024 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc., (NASDAQ:TVTX) today announced that company management will present at the H.C. Wainwright 3rd Annual Kidney Virtual Conference on Monday, July
Shareholders in Travere Therapeutics (NASDAQ:TVTX) Are in the Red If They Invested Five Years Ago
Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
SAN DIEGO, June 11, 2024 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc., (NASDAQ:TVTX) today announced that on June 10, 2024, the Compensation Committee of its Board of Directors granted inducement equity grants to